Effects of environmental factors on the in vitro potency of azithromycin J. A. RetsemaL. A. BrennanA. E. Girard In Vitro Studies Pages: 834 - 842
Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin J. A. RetsemaA. E. GirardJ. A. Faiella In Vitro Studies Pages: 843 - 846
Influence of the test medium on azithromycin and erythromycin regression statistics A. L. BarryP. C. Fuchs In Vitro Studies Pages: 846 - 849
An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers P. CoatesR. DanielT. Taylor Pharmacokinetics Pages: 850 - 852
Concentrations of azithromycin in human tonsillar tissue G. FouldsK. H. ChanR. B. Johnson Pharmacokinetics Pages: 853 - 856
Azithromycin concentrations in sinus fluid and mucosa after oral administration P. KarmaJ. PukanderM. Penttilä Pharmacokinetics Pages: 856 - 859
High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose D. L. MorrisA. De SouzaW. E. Morgan Pharmacokinetics Pages: 859 - 861
Azithromycin levels in plasma and gastric tissue, juice and mucus J. D. HarrisonJ. A. JonesD. L. Morris Pharmacokinetics Pages: 862 - 864
Concentration of azithromycin in human prostatic tissue G. FouldsP. MadsenR. Johnson Pharmacokinetics Pages: 868 - 871
Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia G. KinasewitzR. G. Wood Clinical Studies Pages: 872 - 877
Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia S. SchönwaldV. ŠkerkM. Gunjača Clinical Studies Pages: 877 - 880
Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections R. Kiani Clinical Studies Pages: 880 - 884
